|
The 17th Asia Pharma Expo 2026 & Asia Lab Expo 2026, the region’s leading international platform for pharmaceutical manufacturing technology, will take place at the Bangladesh-China Friendship Exhibition Centre (BCFEC), Purbachal, Dhaka, from March 29 to 31, 2026.
Jointly organized by GPE EXPO PVT LTD and the Bangladesh Association of Pharmaceutical Industries (BAPI), the exhibition continues its legacy of over 23 years of driving innovation, collaboration, and industrial excellence in Bangladesh’s fast-growing pharmaceutical sector.
The 2026 edition will host more than 850 exhibiting companies from more than 30 countries, showcasing a complete range of technologies for pharmaceutical processing, packaging, APIs & excipients, analytical & laboratory instruments, cleanroom & HVAC systems, water management, and turnkey project services.
Following the remarkable success of APE 2025—which attracted 14,500 trade visitors and more than 750 exhibitors from 32 countries—the upcoming edition aims to further strengthen international engagement and technology transfer within Bangladesh’s thriving pharma manufacturing ecosystem.
As one of South Asia’s most important B2B trade platforms, Asia Pharma Expo 2026 offers an unmatched opportunity for global suppliers to connect directly with pharmaceutical manufacturers, investors, and project developers who are upgrading production capacities and adopting world-class technologies.
Since 2003, Asia Pharma Expo and Asia Lab Expo have served as the region’s only dedicated exhibitions covering the entire pharmaceutical manufacturing supply chain. The events provide an unparalleled platform for entrepreneurs, R&D specialists, and corporate decision-makers to explore new machinery, raw materials, packaging solutions, and laboratory innovations.
Over the years, the exhibitions have nurtured technological advancement and industry modernization, supporting Bangladesh’s transformation from an import-dependent market to a global exporter of high-quality generic medicines.
Bangladesh’s pharmaceutical sector is a major contributor to its national economy and international trade.
The industry now meets 98 per cent of the country’s medicinal demand and exports to 157 countries worldwide, including the USA, UK, Germany, and Canada. Valued at over US$ 3.5 billion, the market is projected to exceed US$ 6 billion by 2026, growing at an annual rate of 15–18 per cent.
Government initiatives such as the API Industrial Park are accelerating local API production and reducing import dependency—an important step toward achieving API self-sufficiency by 2032.
These developments make Bangladesh one of the most attractive destinations for technology suppliers, equipment manufacturers, and raw-material producers seeking to expand into South Asia.
|